Bio-Techne Corp. Stock Prediction
AI-powered sentiment analysis and prediction trends for TECH, updated each market day.
TECH AI Sentiment
AI sees no strong directional signal for Bio-Techne Corp. stock over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Bio-Techne Corp.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Sector
Exchange
Market Cap
$11,355,208,613
Cap Tier
Employees
3,000
Headquarters
MINNEAPOLIS, MN
Listed Since
May 8, 1989
Website
TECH Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
TECH Volatility
Bio-Techne Corp. has shown low price volatility over the last 5 trading days. Low volatility suggests steady price action with smaller daily moves.
